@twiggs462.bsky.social
Reposted
🚨NEW EPISODE🚨 How do perception and language shape subjectivity? What makes an experience ineffable? And can LSD offer new prospects for treating MDD and GAD? We're joined by @dankarlin.com of MindMed to talk new research trials, neurobiology, and more! www.buzzsprout.com/2131830/epis...
121: LSD: Subjectivity, Ineffability, and Mental Health feat. Dan Karlin - Ordinary Unhappiness
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials u...
www.buzzsprout.com
November 8, 2025 at 3:04 PM
🚨NEW EPISODE🚨 How do perception and language shape subjectivity? What makes an experience ineffable? And can LSD offer new prospects for treating MDD and GAD? We're joined by @dankarlin.com of MindMed to talk new research trials, neurobiology, and more! www.buzzsprout.com/2131830/epis...
Absolutely love this game! Currently playing on my switch. Very hard, but love it. Your art style is great and hits the right nostalgic notes. Thanks for your hard work. I will look into your other games as well.
December 14, 2025 at 10:58 PM
Absolutely love this game! Currently playing on my switch. Very hard, but love it. Your art style is great and hits the right nostalgic notes. Thanks for your hard work. I will look into your other games as well.
Reposted
The first version of #MalditaCastilla was released 13 years ago today!
A dark fantasy sidescroller packed with myths from Spain and inspired by a bunch of mid-to-late 80s arcade games I love. Featuring a super on point FM soundtrack by @gryzor87.bsky.social
Info: locomalito.com
A dark fantasy sidescroller packed with myths from Spain and inspired by a bunch of mid-to-late 80s arcade games I love. Featuring a super on point FM soundtrack by @gryzor87.bsky.social
Info: locomalito.com
December 12, 2025 at 6:02 PM
The first version of #MalditaCastilla was released 13 years ago today!
A dark fantasy sidescroller packed with myths from Spain and inspired by a bunch of mid-to-late 80s arcade games I love. Featuring a super on point FM soundtrack by @gryzor87.bsky.social
Info: locomalito.com
A dark fantasy sidescroller packed with myths from Spain and inspired by a bunch of mid-to-late 80s arcade games I love. Featuring a super on point FM soundtrack by @gryzor87.bsky.social
Info: locomalito.com
$MNMD is on a tear
November 10, 2024 at 3:13 PM
$MNMD is on a tear
Big things coming. Look back into them.
November 10, 2024 at 3:12 PM
Big things coming. Look back into them.
Reposted
“This is important: if #LSD represents a sort of magic, it is a magic of the modern West, in all its horror and promethean glory. For all its alchemical resonance, it sprouts from the brow of industrial chemistry …” aeon.co/essays/how-o...
How outlaw chemists used ‘blotter’ to dose the world with LSD | Aeon Essays
How perforated squares of trippy blotter paper allowed outlaw chemists and wizard-alchemists to dose the world with LSD
aeon.co
May 10, 2024 at 12:11 PM
“This is important: if #LSD represents a sort of magic, it is a magic of the modern West, in all its horror and promethean glory. For all its alchemical resonance, it sprouts from the brow of industrial chemistry …” aeon.co/essays/how-o...
What a great article! Thanks for sharing this piece. Have you looked into what MindMed.co is doing?
Psychedelic Medicine & Therapies | MindMed
MindMed discovers, develops, and deploys psychedelic-inspired medicines to improve health, promote wellness, and alleviate suffering. Learn more about our medicines and therapies today.
MindMed.co
November 10, 2024 at 3:10 PM
What a great article! Thanks for sharing this piece. Have you looked into what MindMed.co is doing?
MindMed is developing MM120, the tartrate salt form of lysergide, for GAD and MDD and is exploring its potential applications in other serious brain health disorders. MM120 (lysergide D-tartrate or LSD) is a synthetic ergotamine belonging to the group of classic psychedelics.
MindMed.co
MindMed.co
November 10, 2024 at 3:01 PM
MindMed is developing MM120, the tartrate salt form of lysergide, for GAD and MDD and is exploring its potential applications in other serious brain health disorders. MM120 (lysergide D-tartrate or LSD) is a synthetic ergotamine belonging to the group of classic psychedelics.
MindMed.co
MindMed.co
$MNMD MindMed Third Quarter 2024 Financial Results & Business Updates
Initiating Phase 3 for Generalized Anxiety Disorder (GAD)
Initiateg Phase 3 for Major Depressive Disorder (MDD)
Cash $295.3 million; fund operations into 2027
ir.mindmed.co/news-events/...
#psychedelics #stock #biotech
Initiating Phase 3 for Generalized Anxiety Disorder (GAD)
Initiateg Phase 3 for Major Depressive Disorder (MDD)
Cash $295.3 million; fund operations into 2027
ir.mindmed.co/news-events/...
#psychedelics #stock #biotech
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
--On track to initiate the Phase 3 Voyage study of MM120 Orally Disintegrating Tablet (ODT) in Generalized Anxiety Disorder (GAD) in the…...
ir.mindmed.co
November 10, 2024 at 2:56 PM
$MNMD MindMed Third Quarter 2024 Financial Results & Business Updates
Initiating Phase 3 for Generalized Anxiety Disorder (GAD)
Initiateg Phase 3 for Major Depressive Disorder (MDD)
Cash $295.3 million; fund operations into 2027
ir.mindmed.co/news-events/...
#psychedelics #stock #biotech
Initiating Phase 3 for Generalized Anxiety Disorder (GAD)
Initiateg Phase 3 for Major Depressive Disorder (MDD)
Cash $295.3 million; fund operations into 2027
ir.mindmed.co/news-events/...
#psychedelics #stock #biotech
@bethmariem.bsky.social Have you checked into this company MindMed? Could be something interesting to write about on Ars.
MindMed.co
MindMed.co
November 10, 2024 at 5:36 AM
@bethmariem.bsky.social Have you checked into this company MindMed? Could be something interesting to write about on Ars.
MindMed.co
MindMed.co
Reposted
$MNMD MindMed (NASDAQ: MNMD) Q3 Snapshot: Advancing Three Phase 3 Trials with Ample Cash
MNMD Q3 Snapshot: Advancing Three Phase 3 Trials with Ample Cash
New York, November 08, 2024 - PRISM MarketView - MindMed (NASDAQ: MNMD) reported its third quarter 2024 financial results and provided significant business updates, highlighting its progress towards…
buff.ly
November 8, 2024 at 4:01 PM
$MNMD MindMed (NASDAQ: MNMD) Q3 Snapshot: Advancing Three Phase 3 Trials with Ample Cash